Key result
Tongxinluo capsule improved symptoms and reduced endothelin in unstable angina patients, with no significant difference versus long-acting isosorbide dinitrate.
Why the study?
Does Tongxinluo capsule improve clinical symptoms and plasma endothelin levels in patients with unstable angina pectoris?
Does Tongxinluo capsule improve clinical symptoms and plasma endothelin levels in patients with unstable angina pectoris?
Tongxinluo capsule appears as effective as long-acting isosorbide dinitrate in improving symptoms and reducing plasma endothelin levels in patients with unstable angina pectoris over 4 weeks.
Answers are grounded in this paper and cite their sources.
Tongxinluo offers symptom relief comparable to isosorbide dinitrate in unstable angina; confirms equivalent efficacy on symptoms and endothelin in this RCT.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2004) studied this question. Tongxinluo capsule improved symptoms and reduced endothelin in unstable angina patients, with no significant difference versus long-acting isosorbide dinitrate.
Synapse has enriched 10 related papers. Consider them for comparative context: